Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 192.00
+1.40 (0.73%)
At close: Jan 30, 2026
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 14.94 billion as of January 30, 2026. Its market cap has decreased by -1.60% in one year.
Market Cap
14.94B
Enterprise Value
12.10B
Revenue
6.89B
Ranking
n/a
PE Ratio
6.23
Stock Price
192.00
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 14.94B, an increase of 34,886.44%. That is a compound annual growth rate of 23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 14.94B | 0.04% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.64T |
| Genmab | 124.55B |
| Coloplast | 120.80B |
| Demant | 46.95B |
| H. Lundbeck | 40.70B |
| Zealand Pharma | 29.59B |
| Ambu A/S | 22.62B |
| GN Store Nord | 16.17B |